These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Bone disorders in cholestatic liver diseases. Isaia G; Di Stefano M; Roggia C; Ardissone P; Rosina F Forum (Genova); 1998; 8(1):28-38. PubMed ID: 9514992 [TBL] [Abstract][Full Text] [Related]
24. [Diet in liver diseases]. Strohmeyer G Z Allgemeinmed; 1974 Jan; 50(2):50-2. PubMed ID: 4816783 [No Abstract] [Full Text] [Related]
25. Treatment of diseases of the liver. Berris B Appl Ther; 1968 Apr; 10(4):262-4. PubMed ID: 5655423 [No Abstract] [Full Text] [Related]
26. [Therapy of chronic liver diseases]. Geisenhainer G Z Arztl Fortbild (Jena); 1972 Dec; 66(23):1199-201. PubMed ID: 4652157 [No Abstract] [Full Text] [Related]
27. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection? Hay JE Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489 [TBL] [Abstract][Full Text] [Related]
29. [Diet therapy of chronic liver diseases with special reference to protein requirements]. Vetter K; Kaschube I; Aust L Dtsch Gesundheitsw; 1969 Dec; 24(52):2459-65. PubMed ID: 5375929 [No Abstract] [Full Text] [Related]
30. [Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis]. Strassburg CP; Manns MP Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S96-8. PubMed ID: 12817335 [No Abstract] [Full Text] [Related]
31. Guidelines for therapy of autoimmune liver disease. Ishibashi H; Komori A; Shimoda S; Gershwin ME Semin Liver Dis; 2007 May; 27(2):214-26. PubMed ID: 17520519 [TBL] [Abstract][Full Text] [Related]
35. [Pathophysiologic, pathomorphologic and clinical principles of a rational liver therapy]. Franken FH Hippokrates; 1971 Mar; 42(1):25-39. PubMed ID: 5550582 [No Abstract] [Full Text] [Related]
36. [Hyperbaric oxygen therapy for hepatic insufficiency (compared with other current methods of treatment)]. Ohresser P; Sahel J; Girbal JP; Gauthier A Mars Med; 1969; 106(4):313-9. PubMed ID: 5383413 [No Abstract] [Full Text] [Related]
37. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence. Seyam M; Neuberger JM; Gunson BK; Hübscher SG Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332 [TBL] [Abstract][Full Text] [Related]
38. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847 [TBL] [Abstract][Full Text] [Related]
39. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Malik SM; Ahmad J Liver Transpl; 2010 Apr; 16(4):533. PubMed ID: 20373463 [No Abstract] [Full Text] [Related]
40. Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups. Longworth L; Young T; Buxton MJ; Ratcliffe J; Neuberger J; Burroughs A; Bryan S; Liver Transpl; 2003 Dec; 9(12):1295-307. PubMed ID: 14625830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]